Home
>
National Drug Code (NDC)
>
Tarka
Tarka - 0074-3287-13 - (Trandolapril and Verapamil Hydrochloride)
Drug Information of Tarka
| Product NDC: | 0074-3287 |
| Proprietary Name: | Tarka |
| Non Proprietary Name: | Trandolapril and Verapamil Hydrochloride |
| Active Ingredient(s): | 2; 180 mg/1; mg/1 & nbsp; Trandolapril and Verapamil Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tarka
| Product NDC: | 0074-3287 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020591 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19961022 |
Package Information of Tarka
| Package NDC: | 0074-3287-13 |
| Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3287-13) |
NDC Information of Tarka
| NDC Code | 0074-3287-13 |
| Proprietary Name | Tarka |
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3287-13) |
| Product NDC | 0074-3287 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Trandolapril and Verapamil Hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19961022 |
| Marketing Category Name | NDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE |
| Strength Number | 2; 180 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |
